Dermatologic Drugs During Pregnancy and Lactation

Katherine B. Lee, Teri M. Greiling

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This chapter identifies and discusses recommendations and contraindications to various drugs in pregnancy and lactation. When treatment with one of these drugs is essential, data must be carefully examined and evaluated, so that a risk–benefit ratio may be determined. In addition, the benefits of breastfeeding are numerous, so any decision to limit breastfeeding must be justified by the fact that the risk to the baby clearly outweighs the benefits offered by breastfeeding. It is crucial to have both patient and physician take part in the decision-making process.

Original languageEnglish (US)
Title of host publicationComprehensive Dermatologic Drug Therapy, Fourth Edition
PublisherElsevier
Pages710-724.e4
ISBN (Electronic)9780323612111
ISBN (Print)9780323612128
DOIs
StatePublished - Jan 1 2020

Keywords

  • breastfeeding
  • drugs
  • lactation
  • pregnancy
  • toxicity

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Dermatologic Drugs During Pregnancy and Lactation'. Together they form a unique fingerprint.

Cite this